|
Delayed
Bombay S.E.
07:42:43 11/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 2,720.00 INR | -2.61% |
|
-3.28% | +47.63% |
| 08-14 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| 08-12 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 28.52x | 4.69x | - | - | - | 2.22B | |
| 0.92% | 1.07% | 34.41x | 4.82x | 6.46x | 22.37x | 27.07x | 46.7B | |
| 1.54% | 1.63% | 16.75x | 1.87x | 2.07x | 9.21x | 11.69x | 39.11B | |
| 0.6% | 0.63% | 27.03x | 3.72x | 3.86x | 16.02x | 22.43x | 11.66B | |
| 0.95% | 1.08% | 26.53x | 2.93x | 3.21x | 16.64x | 21.35x | 11.6B | |
| 3.84% | 3.92% | 18.81x | 3.26x | 3.34x | 11.63x | 13.85x | 9.19B | |
| 4.7% | 5.35% | 9.21x | 1.52x | 2.11x | 5.46x | 6.69x | 7.27B | |
| 0.16% | 0.17% | 29.62x | 5.44x | 3.87x | 18.02x | 21.73x | 7.13B | |
| 3.32% | 3.29% | 15.17x | 1.26x | 1.97x | 6.56x | 9.17x | 7.15B | |
| 0.94% | 1.09% | 35.18x | 8.15x | 6.87x | 25.07x | 27.68x | 4.6B | |
| 1.68% | 1.56% | 16.05x | 0.78x | 2.21x | 9.45x | 11.95x | 4.3B | |
| 3.64% | 4.13% | 14.43x | 2.42x | 2.39x | 10.74x | 10.57x | 3.67B | |
| 2.99% | 3.1% | 16.34x | 2.89x | 3.31x | 12.46x | 14.87x | 2.87B | |
| 3.05% | 3.46% | 19.78x | 5.02x | 5.64x | 16.92x | 18.51x | 2.56B | |
| Average | 2.18% | 2.34% | 21.99x | 3.48x | 3.64x | 13.89x | 16.73x | 11.43B | |
| Weighted average by Cap. | 1.63% | 1.76% | 24.30x | 3.41x | 3.97x | 15.09x | 18.60x |
Select your edition
All financial news and data tailored to specific country editions
